About Kindstar
Kindstar is a publicly listed company based in Wuhan (China) founded in 2003. Specialized medical testing services are provided nationwide. Kindstar has raised $31 million across 4 funding rounds from investors including Kleiner Perkins, WI Harper Group and Investcorp. The company has 3,010 employees. Kindstar offers products and services including Hematology Testing and Genetic Testing. Its focus areas include Clinical Laboratories and Pathology. Its legal entity is Wuhan Kang Sheng Da Medical Laboratory Co., Ltd.
Company details
Founded in 2003 in Wuhan, China, Kindstar operates in the medical diagnostics sector. A network of laboratories is maintained to support hospitals across the country with tests in hematology, genetics, gynecology, infectious diseases, neurology, oncology, and routine areas. Advanced technologies, including flow cytometry, PCR, sequencing, and mass spectrometry, are employed to ensure accurate results for healthcare professionals.
- Headquarters Wuhan, China
- Employees 3,010
- Stage Public
- SectorsHealthcare
- Website kindstar.com.cn
- Social LinkedIn
- Legal Name Kindstar Globalgene Technology, Inc.
- Annual Revenue$129.75 M (USD)0.67as on Dec 31, 2025
- Net Profit-$8.18 M (USD)-7.64as on Dec 31, 2025
- EBITDA-$8.1 M (USD)-17.06as on Dec 31, 2025
- Total Equity Funding$31M (USD)
in 4 rounds
- InvestorsKleiner Perkins
& 6 more
- Employee Count3,010
Products & Services of Kindstar
Kindstar offers a comprehensive portfolio of products and services, including Hematology Testing and Genetic Testing.
Over 2300 testing items for blood-related diseases are provided to support diagnosis of conditions like leukemia and clotting disorders.
More than 400 tests for genetic and rare diseases are offered using techniques such as sequencing and flow cytometry.
Funding Insights of Kindstar
Kindstar has successfully raised a total of $31M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31M
- Total Rounds 4
- Investors Count 7
All 4 funding rounds of Kindstar with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | Series D | – | Investcorp | – | |
| Mar 2012 | $20M | Series C | – | Kleiner Perkins | |
| Jun 2011 | $11M | Series B | – | WI Harper Group | |
| Jun 2008 | Series A | – | – |
7 investors in total: 7 institutional.
Investors in Kindstar
Kindstar has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, WI Harper Group and Investcorp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity, real estate, and credit investments are managed globally. | investcorp.com | New York, United States | ||
Global private equity and venture capital investments in B2B Tech & Services companies. | bairdcapital.com | |||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Healthcare startups are accelerated by Mayo Clinic Business Accelerator. | mcbusaccel.com | Rochester, United States | ||
VC firm that does investment in early stage companies in the US & China | 1993 | wiharper.com | San Francisco, United States | |
A venture capital firm focused on technology and innovation investments. | 5ycap.com | Shanghai, China | ||
VC and private equity investments are made in China-US companies. | morningside.com.cn | Shanghai, China |
Investor details for Kindstar
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Kindstar
Kindstar is a publicly listed company on the HKEX with ticker symbol 9960 in Hong Kong, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date16 Jul 2021
- Listed onHKG: 9960
- Listed entityKindstar Globalgene Technology, Inc.
- Exchange sectorHealth services
- ISINKYG5262E1044
- Share price0.90 HKD (-3.74% on the day) · 2026-10-14
- Market capitalisation973,640,430.00 HKD
- EPS (diluted, trailing year)-0.05 HKD
- Dividend yield10.16%
- Volume (last session)781,500
Financials of Kindstar
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 1.01B HKD | -63.7M HKD | -63.1M HKD |
| 2024 | 1.01B HKD | -59.2M HKD | -53.9M HKD |
| 2023 | 1.07B HKD | 45.6M HKD | 5.6M HKD |
| 2022 | 1.61B HKD | 87.8M HKD | 111.5M HKD |
| 2021 | 1.12B HKD | -1.75B HKD | 107.4M HKD |
Detailed financial statements for Kindstar
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Kindstar
4 dated milestones of Kindstar across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Kindstar is founded.
- Funding First funding round.
- Funding Latest funding round, Series D,.
- IPO Lists on the stock exchange (IPO).
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Kindstar
Complete news archive for Kindstar
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kindstar
Kindstar was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Kindstar is headquartered in Wuhan, China. It is registered at Wuhan, Hubei, China.
Kindstar is a funded company, having raised a total of $31M across 4 funding rounds to date.
Kindstar has 3,010 employees.
Annual revenue of Kindstar is $129.75M as on Dec 31, 2025.
Founded in 2003 in Wuhan, China, Kindstar operates in the medical diagnostics sector. A network of laboratories is maintained to support hospitals across the country with tests in hematology, genetics, gynecology, infectious diseases, neurology, oncology, and routine areas. Advanced technologies, including flow cytometry, PCR, sequencing, and mass spectrometry, are employed to ensure accurate results for healthcare professionals.
Kindstar offers Hematology Testing and Genetic Testing.
Yes, Kindstar is publicly traded on HKEX under the ticker symbol 9960.
Kindstar has 7 investors. Key investors include Kleiner Perkins, WI Harper Group, Investcorp, Baird Capital, and Mayo Clinic Business Accelerator.
Kindstar operates through Wuhan Kang Sheng Da Medical Laboratory Co., Ltd.